Vaccines
Study finds no increased risk of rare neurological events after covid vaccination.
18 Mar, 2022 | 09:31h | UTCNews Release: Study finds no increased risk of rare neurological events after covid vaccination – BMJ Newsroom
Editorial: The neurological safety of covid-19 vaccines
Among health care workers, a fourth dose vaccine effectiveness against any SARS-CoV-2 Omicron variant infection was 30% for the Pfizer–BioNTech and 11% for the Moderna.
17 Mar, 2022 | 09:12h | UTCEfficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron – New England Journal of Medicine
Related: [Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.
Effectiveness of the Sputnik V, AstraZeneca, and Sinopharm vaccines for the risk of infection and death due to COVID-19 in people older than 60 years in Argentina.
17 Mar, 2022 | 09:10h | UTCCommentary: Evaluating COVID-19 vaccines in the real world – The Lancet
Trends in HPV–associated cancers, demographic characteristics, and vaccinations in the US, 2001-2017.
17 Mar, 2022 | 08:16h | UTCAuthor Interview: Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations
Related:
Three-year follow-up of 2-dose versus 3-dose HPV vaccine
CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination
Meta-Analysis: Population-level Impact of HPV Vaccination Programs
[Preprint] High vaccine effectiveness against severe Covid-19 in the elderly in Finland before and after the emergence of Omicron.
15 Mar, 2022 | 09:59h | UTC
Commentary on Twitter
The acid test for Covid vaccines are protection of the elderly. New data from ~900,000 Finns age 70+ show how 3 shots achieved 96% effectiveness vs hospitalization, before and after Omicron, and even higher vs ICU need https://t.co/TQOQV4SL9a Spikevax=Moderna; Comirnaty=Pfizer pic.twitter.com/mtUCqne1dT
— Eric Topol (@EricTopol) March 14, 2022
Another study suggests that a third vaccine dose is necessary to protect populations against the omicron variant.
11 Mar, 2022 | 10:14h | UTCNews Release: Third vaccine dose critical for protecting populations against omicron variant – BMJ Newsroom
Commentary on Twitter
mRNA vaccines are highly effective in preventing covid-19 associated hospital admissions related to the alpha, delta, and omicron variants. But three doses are needed to achieve a similar level of protection against omicron, finds a large US study: https://t.co/YMm176gmby
— The BMJ (@bmj_latest) March 10, 2022
WHO says COVID boosters needed, reversing previous call.
9 Mar, 2022 | 09:49h | UTCWHO says COVID boosters needed, reversing previous call – Associated Press
Commentary on Twitter
Who needs a booster? The @WHO reverses its position and supports "urgent and broad" 3-shot vaccination https://t.co/y5pyY9bJr7 @AP The evidence has supported that move for several months.
"Fully vaccinated" = 3-shots
(or confirmed infection-acquired immunity + 1 shot)— Eric Topol (@EricTopol) March 8, 2022
[News release – not published yet] New Sanofi and GSK vaccine demonstrates strong protection against severe Covid-19 in clinical trials.
8 Mar, 2022 | 08:53h | UTCCommentary: New vaccine demonstrates strong protection against severe Covid-19 in clinical trials – CNN
News Release: Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine
M-A: Efficacy of covid-19 vaccines in immunocompromised patients.
4 Mar, 2022 | 10:01h | UTCNews Release: Study suggests additional covid-19 vaccine doses for immunocompromised patients – BMJ Newsroom
Related: Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review.
Commentary on Twitter
NEW RESEARCH: Additional doses of covid-19 vaccine are recommended for immunocompromised patients, especially for organ transplant recipients who are least able to make antibodies to fight off coronavirus, suggests new research https://t.co/l2IWfSb0zd @sundar__raghav
— The BMJ (@bmj_latest) March 3, 2022
Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.
3 Mar, 2022 | 08:43h | UTCMyocarditis Following COVID-19 BNT162b2 Vaccination Among Adolescents in Hong Kong – JAMA Pediatrics
Commentary: Study: Dosing change could reduce COVID-19 vaccine heart side effect in teens – UPI
Related:
Myocarditis after BNT162b2 vaccination in Israeli adolescents.
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
[Preprint] Study shows significantly reduced effectiveness of the Pfizer vaccine in children 5 to 11 after the emergency of the Omicron variant.
1 Mar, 2022 | 08:54h | UTCCommentaries:
Pfizer Covid vaccine is less effective in kids 5 to 11, study finds – STAT
More mask mandates fall as poor COVID vaccine protection noted in young kids – CIDRAP
Study suggests multisystem inflammatory syndrome in children (MIS-C) is rare among vaccinated teens.
25 Feb, 2022 | 11:29h | UTCCommentaries:
When vaccine adverse event reporting generates hope, not fear – The Lancet Child & Adolescent Health
MIS-C rare in COVID-vaccinated teens, study finds – CIDRAP
Vaccination Greatly Reduces Odds of MIS-C in Teens Who Get COVID – HealthDay
Commentary on Twitter
New study from @CDCgov finds that multi-system inflammatory syndrome in children (#MISC) is rare among 12 to 20-year-olds who have received #COVID19 vaccination (1.0 case per million individuals receiving one or more doses)https://t.co/BpsXSpMMcH
— The Lancet Child & Adolescent Health (@LancetChildAdol) February 23, 2022
Editorial: Addressing vaccine inequity — Covid-19 vaccines as a global public good.
24 Feb, 2022 | 10:41h | UTC
RCT: Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine.
24 Feb, 2022 | 10:20h | UTCCommentary: Suspend Methotrexate for RA Patients Getting COVID Vax?— It’s not a simple choice, Brazilian study suggests (free registration required)
[Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.
24 Feb, 2022 | 10:30h | UTCFourth dose of COVID vaccine offers only slight boost against Omicron infection – Nature
Original Study: 4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC – medRxiv
Two large populational-based studies find a slightly increased risk of thrombotic events following AstraZeneca COVID-19 vaccination.
24 Feb, 2022 | 10:23h | UTCCommentaries:
Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax – TCTMD
Meta-analysis finds low risk of a second allergic reaction to SARS-CoV-2 mRNA vaccines in patients with an allergic reaction with the first dose.
22 Feb, 2022 | 10:05h | UTC
Commentary on Twitter
Systematic review and meta-analysis of 22 studies and 1366 patients found that there was a low risk of repeat allergic reaction to a second #COVID19 mRNA vaccine dose in people who had immediate allergic reaction with the first dose. https://t.co/NQSXBJwa6r
— JAMA Internal Medicine (@JAMAInternalMed) February 21, 2022
Opinion by Dr. Eric Topol | Why one-shot after a Covid-19 infection should suffice to be considered fully-vaxxed.
22 Feb, 2022 | 10:07h | UTCWhy one-shot after a Covid-19 infection should suffice to be considered fully-vaxxed – The Guardian
Commentary from the author on Twitter (thread – click for more)
My new essay @guardian
"Why one-shot after a Covid-19 infection should suffice to be considered fully-vaxxed"https://t.co/RaBUpET2CZ
Summarizes extensive new evidence that confirmed Prior Covid ("Natural Immunity" or NI) + 1-shot is as protective as 3-shots /1— Eric Topol (@EricTopol) February 20, 2022
[Preprint] A large-scale observational study in Chile found CoronaVac (an inactivated SARS-CoV-2 vaccine) was associated with an effectiveness of 74.5% against infection, 91.0% against hospitalization, and 93.8% against ICU admission in children aged 6 to 16 years.
22 Feb, 2022 | 09:58h | UTCCommentary: Full schedule of CoronaVac vaccine shown to be highly effective in children – News Medical
Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis.
21 Feb, 2022 | 09:33h | UTC
New U.S. childhood and adolescent immunization schedule released by ACIP.
18 Feb, 2022 | 10:05h | UTCRecommended Childhood and Adolescent Immunization Schedule: United States, 2022 – Pediatrics
See also:
New U.S. adult immunization schedule released by ACIP.
18 Feb, 2022 | 10:07h | UTCRecommended Adult Immunization Schedule, United States, 2022 – Annals of Internal Medicine
Cohort study: Protection against SARS-CoV-2 after Covid-19 vaccination lasts longer in patients with previous infection.
17 Feb, 2022 | 10:11h | UTC
Retrospective cohort study: Pfizer vaccine reduces the risk of reinfection after recovery from Covid-19.
17 Feb, 2022 | 10:13h | UTCEffectiveness of the BNT162b2 Vaccine after Recovery from Covid-19 – New England Journal of Medicine
Commentary on Twitter
Among patients who had recovered from Covid-19, the receipt of at least one dose of the BNT162b2 vaccine was associated with a significantly lower risk of recurrent infection. https://t.co/AAlsY9sFlv pic.twitter.com/Nkj1lP77ZW
— NEJM (@NEJM) February 16, 2022
England to offer Covid jab to five to 11-year-olds.
17 Feb, 2022 | 10:09h | UTCEngland to offer Covid jab to five to 11-year-olds – BBC